Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
American Journal of Therapeutics(2)
Current Pharmaceutical Design(2)
Revista Latinoamericana de Hipertension(2)
Current Hypertension Reports(1)
Área temáticas
Enfermedades(4)
Fisiología humana(4)
Farmacología y terapéutica(2)
Salud y seguridad personal(2)
Alimentación y bebidas(1)
Origen
scopus(7)
Exploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusObesity genetics: A monopoly game of genes
ArticleAbstract: Obesity is a complex disease that affects all ethnic populations worldwide. The etiology of this disPalabras claves:Epigenetics, Monogenic syndromes, obesity, Thrifty genotype, Thrifty phenotypeAutores:Aguirre M.A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPharmacologic treatment of obesity: Pitfalls and new promises
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease with increasing prevalence acquiring pandemic pPalabras claves:body mass index, Energetic balance, Noradrenergic agents, obesity, Orlistat, Serotoninergic agents, SibutramineAutores:Ciszek A., Colmenares C., González M.C., Gotera D., Guerra-Torres X.E., Luti Y., Nuñez M., Rodriguez M., Rojas-Quintero J., Urdaneta I., Valdelamar L., Valmore Bermúdez, Velasco M.Fuentes:scopusSingle-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: Insulin resistance and type 2 diabetes mellitus candidate genes
ArticleAbstract: It has already been a decade and a half since the discovery of adiponectin and its role as an insuliPalabras claves:adiponectin, Insulin Resistance, Leptin resistance, obesity, Type 2 DiabetesAutores:Arráiz N., Canelón R., Pacheco M., Rodríguez-Molina D., Rojas E.R., Rojas-Quintero J., Suárez-Ognio L., Toledo A.C., Valmore Bermúdez, Vega K., Velasco M.Fuentes:scopusRole of dietary polyphenols in adipose tissue browning: A narrative review
ReviewAbstract: Lifestyle modifications such as energy restriction and increased physical activity are highly effectPalabras claves:Adipose tissue browning, energy expenditure, Nutraceuticals, obesity, Polyphenols, ThermogenesisAutores:Cano-Ponce C., Carrasquero R., Castro A., Diaz M.P., D’marco L., Garrido B., González M.C., Pérez J.L., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusPrevalence, awareness, management of hypertension and association with metabolic abnormalities: The Maracaibo city metabolic syndrome prevalence study
ArticleAbstract: Background: The purpose of this study was to determine the prevalence and epidemiologic behavior ofPalabras claves:Arterial hypertension, Cardiovascular disease, diabetes mellitus, Latin America, obesity, PREVALENCEAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Calvo M.J., Gómez M.C., González M.C., Gonzalez R., Israili Z.H., Lopez-Miranda J., Lubo A., Martínez M.S., Olivar L.C., Rojas E.R., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopusThe role of adiponectin in endothelial dysfunction and hypertension
ArticleAbstract: It has been two decades since the discovery of adiponectin, and today its role in insulin resistancePalabras claves:adiponectin, Endothelial dysfuction, Hypertension, Nitric oxide, obesity, renin-angiotensin-aldosterone systemAutores:Bolli P., Faria J., Fidilio E., Israili Z.H., Rodríguez-Molina D., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopus